Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Current Leases (2019 - 2024)

Historic Current Leases for Serina Therapeutics (SER) over the last 4 years, with Q2 2024 value amounting to $200000.0.

  • Serina Therapeutics' Current Leases changed N/A to $200000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $200000.0, marking a year-over-year change of. This contributed to the annual value of $214000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2024, Serina Therapeutics' Current Leases is $200000.0.
  • Serina Therapeutics' 5-year Current Leases high stood at $325000.0 for Q1 2020, and its period low was $109000.0 during Q3 2020.
  • Its 3-year average for Current Leases is $212166.7, with a median of $210500.0 in 2023.
  • Over the last 5 years, Serina Therapeutics' Current Leases had its largest YoY gain of 4643.73% in 2020, and its largest YoY loss of 7386.09% in 2020.
  • Quarter analysis of 3 years shows Serina Therapeutics' Current Leases stood at $109000.0 in 2020, then soared by 96.33% to $214000.0 in 2023, then decreased by 6.54% to $200000.0 in 2024.
  • Its last three reported values are $200000.0 in Q2 2024, $207000.0 for Q1 2024, and $214000.0 during Q4 2023.